Company Search:
Advanced Search
Sponsored Links
Tenax Therapeutics Inc Company Snapshot
Tenax Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tenax Therapeutics Inc with three other companies in this sector in UNITED STATES : Plandai Biotechnology Inc (2014 sales of $265,748.00 of which 100% was Meat Processing & Distribution), Ocera Therapeutics Inc ($341,000.00 of which 100% was Molecule Therapeutics), and Boston Therapeutics Inc ($199,582.00 of which 100% was Sugardown TM).

Sales Analysis.
  Stock Performance Chart for Tenax Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (7/31/2020): 1.33
(Figures in U.S. Dollars)
1 Week 11.8%   13 Weeks 47.3%  
4 Weeks 111.8%   52 Weeks 5.6%  
Tenax Therapeutics Inc Key Data:
  Ticker: TENX Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2014 Sales 288,726
(Year Ending Jan 2015).
Employees: 10
  Currency: U.S. Dollars Market Cap: 10,650,963
  Fiscal Yr Ends: December Shares Outstanding: 8,008,243
  Share Type: Common Closely Held Shares: 506,092
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.